IFG Advisors’s AbbVie ABBV Stock Holding History

IFG Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	5,259 +359	+7%	+$77.2K	0.18%	58
2026 Q1	$1.07M	Hold	4,900	–	–	0.17%	59
2025 Q4	$1.12M	Hold	4,900	–	–	0.19%	57
2025 Q3	$1.13M	Hold	4,900	–	–	0.19%	58
2025 Q2	$910K	Hold	4,900	–	–	0.15%	63
2025 Q1	$1.03M	Hold	4,900	–	–	0.2%	54
2024 Q4	$871K	Sell	4,900 -306	-6%	-$56.3K	0.17%	58
2024 Q3	$1.03M	Hold	5,206	–	–	0.22%	48
2024 Q2	$893K	Hold	5,206	–	–	0.21%	51
2024 Q1	$948K	Sell	5,206 -5	-0.1%	-$862	0.25%	44
2023 Q4	$808K	Buy	5,211 +487	+10%	+$71K	0.24%	47
2023 Q3	$704K	Hold	4,724	–	–	0.25%	45
2023 Q2	$636K	Sell	4,724 -214	-4%	-$31.4K	0.23%	52
2023 Q1	$787K	Sell	4,938 -65	-1%	-$9.94K	0.31%	38
2022 Q4	$809K	Sell	5,003 -314	-6%	-$48.1K	0.35%	37
2022 Q3	$714K	Hold	5,317	–	–	0.36%	38
2022 Q2	$814K	Hold	5,317	–	–	0.41%	34
2022 Q1	$862K	Buy	5,317 +2,493	+88%	+$362K	0.38%	39
2021 Q4	$382K	Hold	2,824	–	–	0.16%	75
2021 Q3	$305K	Hold	2,824	–	–	0.14%	81
2021 Q2	$318K	Hold	2,824	–	–	0.15%	79
2021 Q1	$306K	Hold	2,824	–	–	0.17%	69
2020 Q4	$303K	Hold	2,824	–	–	0.19%	65
2020 Q3	$249K	Buy	2,824 +231	+9%	+$21.7K	0.18%	75
2020 Q2	$255K	Buy	+2,593	New	+$228K	0.2%	68

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IFG Advisors's ABBV Position: Q2 2026 in Review

IFG Advisors increased its AbbVie (ABBV) stake by 7.3% in Q2 2026, buying an estimated $77.2K and bringing the position to 5,259 shares worth $1.32M. The position accounts for 0.18% of the portfolio, ranked #58.

IFG Advisors first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

IFG Advisors held 5,259 shares of AbbVie worth $1.32M as of Q2 2026.
IFG Advisors bought 359 AbbVie shares in Q2 2026, an estimated $77.2K.
AbbVie made up 0.18% of IFG Advisors's portfolio in Q2 2026, its #58 holding.
IFG Advisors first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IFG Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.